Eye Tumors: The Silent Threat to Vision – Know the Signs and Treatments
DOI:
https://doi.org/10.5281/zenodo.20675876Keywords:
Eye tumors, benign, malignant, MRI, biopsyAbstract
Eye tumors are not very common, but they can be very dangerous to vision and, in some cases, to life. These unusual growths can be either benign or malignant, and they can start in the eye (primary tumors) or spread from other parts of the body (secondary tumors). Benign tumors like nevus, hemangioma, and choroidal osteoma are usually not cancerous, but they can still make it hard to see, depending on how big and where they are. Malignant tumors, such as retinoblastoma in children, uveal melanoma in adults, and ocular lymphoma, present significant health hazards due to their capacity for local invasion and systemic dissemination. The clinical presentation varies significantly but typically encompasses blurred vision, visual field defects, alterations in iris color, ocular swelling, photopsia, floaters, or ocular pain. Early detection is very important for keeping vision and improving chances of survival. Ophthalmoscopy, ultrasonography, and advanced imaging techniques like MRI or CT scans are all used to make a diagnosis. A biopsy is done when it is needed to make a final diagnosis. Management strategies depend on the type, size, and stage of the tumor. They can range from watching small benign lesions to laser therapy, radiotherapy, chemotherapy, or surgery, including enucleation in severe cases. Regular eye exams, protection from UV rays, a diet high in nutrients, and not smoking are all ways to keep your eyes healthy and lower your risk. This review emphasizes the significance of awareness, prompt diagnosis, and suitable management of ocular tumors to avert permanent vision impairment and systemic complications.
References
Kircher CH, Garner FM, Robinson FR. Tumours of the eye and adnexa. Bulletin of the World Health Organization. 1974;50(1-2):135.
Sunderraj P. Malignant tumours of the eye and adnexa. Indian journal of ophthalmology. 1991 Jan 1;39(1):6-8.
Hartridge H, Thomson LC. Methods of investigating eye movements. The British journal of ophthalmology. 1948 Sep;32(9):581.
Sinha A, Aneesh RP. Eye tumour detection using deep learning. In2021 seventh international conference on bio signals, images, and instrumentation (ICBSII) 2021 Mar 25 (pp. 1-5). IEEE.
Wildner G. Tumors, tumor therapies, autoimmunity and the eye. Autoimmunity Reviews. 2021 Sep 1;20(9):102892.
Dick A. Ocular Tumours: Diagnosis and Treatment. London: BMJ Books; 2001.
Maheshwari A, Finger PT. Cancers of the eye. Cancer and Metastasis Reviews. 2018 Dec 15;37(4):677-90.
Swanzy HR, Panas. A Discussion On The Diagnosis Of Orbital Tumours. The British Medical Journal. 1895 Oct 19:953-7.
Christiansen J, Mathiasen R, Heegaard S, Kjeldsen S, Schmiegelow K, Siersma V, von Holstein SL. Early ophthalmological tumour signs and diagnostic interval in children with brain tumours. Eye. 2025 May 17:1-8.
Milman T, Grossniklaus HE, Goldman-Levy G, Kivelä TT, Coupland SE, White VA, Mudhar HS, Eberhart CG, Verdijk RM, Heegaard S, Gill AJ. The 5th edition of the World Health Organization classification of tumours of the eye and orbit. Ocular oncology and pathology. 2023 Sep 1;9(3-4):71-95.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Haziel Rynjah (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright. Licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/ (CC BY 4.0 deed)